✦ LIBER ✦

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

✍ Scribed by M. Hassan; G. Öberg; H. Ehrsson; M. Ehrnebo; I. Wallin; B. Smedmyr; T. Tötterman; S. Eksborg; B. Simonsson

Publisher: Springer
Year: 1989
Tongue: English
Weight: 630 KB
Volume: 36
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00558081

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of high-dose busulphan

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

✍ M. Hassan; G. Öberg; A. N. Bekassy; J. Aschan; H. Ehrsson; P. Ljungman; G. Lönne 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 532 KB

Pharmacokinetics of high-dose melphalan

Pharmacokinetics of high-dose melphalan in children and adults

✍ Alain Gouyette; Olivier Hartmann; José-Luis Pico 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 429 KB

Pharmacokinetics of high-dose intravenou

Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis

✍ Claude Ardiet; Brigitte Tranchand; Pierre Biron; Paul Rebattu; Thierry Philip 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 506 KB

Pharmacokinetic studies of high-dose met

Pharmacokinetic studies of high-dose metoclopramide with and without forced diuresis

✍ Ell, Ch. ;Braun, J. ;König, H. J. ;Domschke, S. ;Domschke, W. 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 383 KB

Epirubicin metabolism and pharmacokineti

Epirubicin metabolism and pharmacokinetics after conventional- and high-dose intravenous administration: a cross-over study

✍ Carlo M. Camaggi; Elena Strocchi; Patrizia Carisi; Andrea Martoni; Barbara Melot 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 1008 KB

High-dose methotrexate pharmacokinetics

High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma

✍ Kristine R. Crews; Tiebin Liu; Carlos Rodriguez-Galindo; Ming Tan; William H. Me 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract ## BACKGROUND High‐dose methotrexate (HDMTX) is used frequently in combination regimens that include nephrotoxic chemotherapy. The authors evaluated the impact of factors such as age and prior nephrotoxic agents on MTX pharmacokinetics in children and young adults with osteosarcoma and